Skip to main content
Study

Effect of US Drug Enforcement Administration's rescheduling of hydrocodone combination analgesic products on opioid analgesic prescribing.

Jones CM, Lurie PG, Throckmorton DC. Effect of US Drug Enforcement Administration's Rescheduling of Hydrocodone Combination Analgesic Products on Opioid Analgesic Prescribing. JAMA Intern Med. 2016;176(3):399-402. doi:10.1001/jamainternmed.2015.7799.

Save
Print
November 23, 2016
Jones CM, Lurie PG, Throckmorton DC. JAMA Intern Med. 2016;176(3):399-402.

Improving the safety associated with opioid use is a major health policy priority. Investigators found that drug scheduling changes imposed by the US Drug Enforcement Administration (including tighter prescribing standards and prohibiting refills) led to major reductions in the prescribing and dispensing of hydrocodone combination analgesic products.

Save
Print
Cite
Citation

Jones CM, Lurie PG, Throckmorton DC. Effect of US Drug Enforcement Administration's Rescheduling of Hydrocodone Combination Analgesic Products on Opioid Analgesic Prescribing. JAMA Intern Med. 2016;176(3):399-402. doi:10.1001/jamainternmed.2015.7799.